AU2001268328A1 - Method of controlling the binding of calmyrin to presenilin - Google Patents

Method of controlling the binding of calmyrin to presenilin

Info

Publication number
AU2001268328A1
AU2001268328A1 AU2001268328A AU6832801A AU2001268328A1 AU 2001268328 A1 AU2001268328 A1 AU 2001268328A1 AU 2001268328 A AU2001268328 A AU 2001268328A AU 6832801 A AU6832801 A AU 6832801A AU 2001268328 A1 AU2001268328 A1 AU 2001268328A1
Authority
AU
Australia
Prior art keywords
calmyrin
presenilin
binding
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268328A
Inventor
Mervyn J. Monteiro
Stacy M. Stabler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Biotechnology Institute UMBI
Original Assignee
University of Maryland Biotechnology Institute UMBI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland Biotechnology Institute UMBI filed Critical University of Maryland Biotechnology Institute UMBI
Publication of AU2001268328A1 publication Critical patent/AU2001268328A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001268328A 2000-06-12 2001-06-11 Method of controlling the binding of calmyrin to presenilin Abandoned AU2001268328A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21093900P 2000-06-12 2000-06-12
US60210939 2000-06-12
PCT/US2001/018838 WO2001096361A1 (en) 2000-06-12 2001-06-11 Method of controlling the binding of calmyrin to presenilin

Publications (1)

Publication Number Publication Date
AU2001268328A1 true AU2001268328A1 (en) 2001-12-24

Family

ID=22784947

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268328A Abandoned AU2001268328A1 (en) 2000-06-12 2001-06-11 Method of controlling the binding of calmyrin to presenilin

Country Status (3)

Country Link
US (1) US6930169B2 (en)
AU (1) AU2001268328A1 (en)
WO (1) WO2001096361A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060229243A1 (en) * 2004-06-21 2006-10-12 Quincy Resource Group, Inc. Aequorin-containing compositions and methods of using same
US8129334B2 (en) 2006-03-31 2012-03-06 The Regents Of The University Of California Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
JP2009532674A (en) * 2006-03-31 2009-09-10 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and for improving normal memory
AU2013204245B2 (en) * 2007-04-12 2016-08-04 The Brigham And Women's Hospital, Inc. Targeting abcb5 for cancer therapy
AU2008239633B2 (en) * 2007-04-12 2014-05-29 The Brigham And Women's Hospital, Inc. Targeting ABCB5 for cancer therapy
CN102038950B (en) * 2009-10-21 2013-12-04 北京师范大学 Novel immune adjuvant and vaccine containing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
US6242587B1 (en) * 1996-10-02 2001-06-05 The University Of North Carolina At Chapel Hill DNA molecules encoding a calcium-integrin binding protein

Also Published As

Publication number Publication date
WO2001096361A1 (en) 2001-12-20
US20020064828A1 (en) 2002-05-30
US6930169B2 (en) 2005-08-16

Similar Documents

Publication Publication Date Title
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU6044201A (en) Improvements to filters
AU2001249463A1 (en) Concrete form assembly
AU3219000A (en) Controlling production
AU2002225625A1 (en) Control variables
AU2001241085A1 (en) Novel leukapheretic filter
AU2001227972A1 (en) Methods to treat alpha-1-antitrypsin deficiency
AU2002214978A1 (en) Beta-Thio-amino acids
AU2001244470A1 (en) Assembly process
AU2001241098A1 (en) Composition
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
AU2001268328A1 (en) Method of controlling the binding of calmyrin to presenilin
AU2001238125A1 (en) Hydristor control means
AU2001272368A1 (en) Method for the preparation of citalopram
AU2001237530A1 (en) Method
AU2002358634A1 (en) Method to control an actuator
AU2001275201A1 (en) Acne-treating composition
AU6435301A (en) Method for making polypyrrole
AU2001254782A1 (en) Manual actuating means
AU2001269283A1 (en) Distributed control method
AU2001241636A1 (en) Halotherapy method
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001244839A1 (en) Thermosetting composition
AUPR102400A0 (en) Filter control
AU2002228975A1 (en) Method